178 related articles for article (PubMed ID: 11248407)
1. Synthesis and cytotoxic effect of 1,3-dihydroxy-9,10-anthraquinone derivatives.
Wei BL; Wu SH; Chung MI; Won SJ; Lin CN
Eur J Med Chem; 2000 Dec; 35(12):1089-98. PubMed ID: 11248407
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
Teng CH; Won SJ; Lin CN
Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
[TBL] [Abstract][Full Text] [Related]
3. Anthraquinone derivatives induce G2/M cell cycle arrest and apoptosis in NTUB1 cells.
Tu HY; Huang AM; Teng CH; Hour TC; Yang SC; Pu YS; Lin CN
Bioorg Med Chem; 2011 Sep; 19(18):5670-8. PubMed ID: 21852140
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
Taher AT; Hegazy GH
Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
[TBL] [Abstract][Full Text] [Related]
5. Thiophene-2-carboxamide derivatives of anthraquinone: A new potent antitumor chemotype.
Volodina YL; Tikhomirov AS; Dezhenkova LG; Ramonova AA; Kononova AV; Andreeva DV; Kaluzhny DN; Schols D; Moisenovich MM; Shchekotikhin AE; Shtil AA
Eur J Med Chem; 2021 Oct; 221():113521. PubMed ID: 34082225
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxic evaluation of two novel anthraquinone derivatives.
Sadeghi-Aliabadi H; Tabarzadi M; Zarghi A
Farmaco; 2004 Aug; 59(8):645-9. PubMed ID: 15262534
[TBL] [Abstract][Full Text] [Related]
7. New 1,4-anthracene-9,10-dione derivatives as potential anticancer agents.
Zagotto G; Supino R; Favini E; Moro S; Palumbo M
Farmaco; 2000 Jan; 55(1):1-5. PubMed ID: 10755224
[TBL] [Abstract][Full Text] [Related]
8. Antitumor agents--CLXVII. Synthesis and structure-activity correlations of the cytotoxic anthraquinone 1,4-bis-(2,3-epoxypropylamino)-9,10-anthracenedione, and of related compounds.
Johnson MG; Kiyokawa H; Tani S; Koyama J; Morris-Natschke SL; Mauger A; Bowers-Daines MM; Lange BC; Lee KH
Bioorg Med Chem; 1997 Aug; 5(8):1469-79. PubMed ID: 9313853
[TBL] [Abstract][Full Text] [Related]
9. Esters of 2-(1-hydroxyalkyl)-1,4-dihydroxy-9,10-anthraquinones with melphalan as multifunctional anticancer agents.
Jin G; You Y; Ahn B
Bioorg Med Chem Lett; 2001 Jun; 11(11):1473-6. PubMed ID: 11378380
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells.
Jin GZ; Jin HS; Jin LL
Arch Pharm Res; 2011 Jul; 34(7):1071-6. PubMed ID: 21811913
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of an anthraquinone derivative (DHAQC) and its effect on induction of G2/M arrest and apoptosis in breast cancer MCF-7 cell line.
Yeap S; Akhtar MN; Lim KL; Abu N; Ho WY; Zareen S; Roohani K; Ky H; Tan SW; Lajis N; Alitheen NB
Drug Des Devel Ther; 2015; 9():983-92. PubMed ID: 25733816
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, Molecular Docking, and Biological Evaluation of New Emodin Anthraquinone Derivatives as Potential Antitumor Substances.
Li Y; Guo F; Chen T; Zhang L; Wang Z; Su Q; Feng L
Chem Biodivers; 2020 Sep; 17(9):e2000328. PubMed ID: 32627416
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel hydroxyanthraquinone nitrogen mustard derivatives as potential anticancer agents via a bioisostere approach.
Zhao LM; Ma FY; Jin HS; Zheng S; Zhong Q; Wang G
Eur J Med Chem; 2015 Sep; 102():303-9. PubMed ID: 26291039
[TBL] [Abstract][Full Text] [Related]
14. Annulation of substituted anthracene-9,10-diones yields promising selectively antiproliferative compounds.
Castro-Castillo V; Suárez-Rozas C; Castro-Loiza N; Theoduloz C; Cassels BK
Eur J Med Chem; 2013 Apr; 62():688-92. PubMed ID: 23454511
[TBL] [Abstract][Full Text] [Related]
15. Design and Syntheses of Novel Fluoroporphyrin-Anthraquinone Complexes as Antitumor Agents.
Yang GL; Zhao SF; Chen NY; Li S
Chem Pharm Bull (Tokyo); 2016; 64(9):1310-4. PubMed ID: 27581635
[TBL] [Abstract][Full Text] [Related]
16. Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.
Tikhomirov AS; Litvinova VA; Andreeva DV; Tsvetkov VB; Dezhenkova LG; Volodina YL; Kaluzhny DN; Treshalin ID; Schols D; Ramonova AA; Moisenovich MM; Shtil AA; Shchekotikhin AE
Eur J Med Chem; 2020 Aug; 199():112294. PubMed ID: 32428792
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
Bioorg Med Chem; 2007 Nov; 15(22):6868-75. PubMed ID: 17822905
[TBL] [Abstract][Full Text] [Related]
18. One Pot and Metal-Free Approach to 3-(2-Hydroxybenzoyl)-1-aza-anthraquinones.
Yuan J; He Q; Song S; Zhang X; Miao Z; Yang C
Molecules; 2019 Aug; 24(16):. PubMed ID: 31434258
[TBL] [Abstract][Full Text] [Related]
19. Effect of the aryl substituent on antitumor activity of 2-substituted-1,4-dihydroxy-9,10-anthraquinones and 2-substituted-anthracene-1,4,9,10-tetraones.
Nam NH; Jin GZ; Tam MN; Ahn BZ
Arch Pharm Res; 1999 Dec; 22(6):592-607. PubMed ID: 10615866
[TBL] [Abstract][Full Text] [Related]
20. 1-Hydroxyanthraquinones Containing Aryl Substituents as Potent and Selective Anticancer Agents.
Sirazhetdinova NS; Savelyev VA; Frolova TS; Baev DS; Klimenko LS; Chernikov IV; Oleshko OS; Sarojan TA; Pokrovskii AG; Shults EE
Molecules; 2020 May; 25(11):. PubMed ID: 32486108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
